# Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease

Study · id `cardio:ct-nct06725810` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06725810](<https://clinicaltrials.gov/study/NCT06725810>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06725810

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1670 participants.

## Technical summary

Registry record NCT06725810. Randomized; no masking; primary purpose treatment. Start 2025-03-27 (actual); primary completion 2029-01-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1670 participants (planned count; ClinicalTrials.gov record NCT06725810, source copy `cardio:ctgov-nct06725810-2025-07-28`, retrieved 2026-10-26)
- Started: 2025-03-27 (actual) (ClinicalTrials.gov record NCT06725810, source copy `cardio:ctgov-nct06725810-2025-07-28`, retrieved 2026-10-26)
- Primary completion: 2029-01-01 (anticipated) (ClinicalTrials.gov record NCT06725810, source copy `cardio:ctgov-nct06725810-2025-07-28`, retrieved 2026-10-26)
- Completion: 2029-02-01 (anticipated) (ClinicalTrials.gov record NCT06725810, source copy `cardio:ctgov-nct06725810-2025-07-28`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06725810, source copy `cardio:ctgov-nct06725810-2025-07-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06725810-2025-07-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease
- Acronym: CANNON
- Condition: Chronic Kidney Disease Associated Anemia
- Intervention (Drug): Enarodustat
- Lead sponsor: Shanghai Zhongshan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Shanghai Zhongshan Hospital (`cardio:org-shanghai-zhongshan-hospital`)

## Provenance

Content hash: ddf30100400d76c51ef7f50e60f2299535ae73a5faad371dacfc3bbfea210773
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
